117 related articles for article (PubMed ID: 7659855)
1. Establishment of a cell line (MCM-B2) from a benign mixed tumour of canine mammary gland.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Res Vet Sci; 1995 May; 58(3):272-6. PubMed ID: 7659855
[TBL] [Abstract][Full Text] [Related]
2. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of a cell line derived from a canine benign mixed mammary tumour into nude mice.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
J Comp Pathol; 1995 Nov; 113(4):383-8. PubMed ID: 8746960
[TBL] [Abstract][Full Text] [Related]
4. The expression of intermediate filaments in canine mammary glands and their tumors.
Hellmén E; Lindgren A
Vet Pathol; 1989 Sep; 26(5):420-8. PubMed ID: 2555958
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
6. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
[TBL] [Abstract][Full Text] [Related]
7. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
8. Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines.
Hellmén E
In Vitro Cell Dev Biol; 1992 May; 28A(5):309-19. PubMed ID: 1375928
[TBL] [Abstract][Full Text] [Related]
9. Giant cells in anaplastic mammary carcinoma of the dog and cat.
Della Salda L; Sarli G; Benazzi C; Marcato PS
J Comp Pathol; 1993 Nov; 109(4):345-60. PubMed ID: 8106667
[TBL] [Abstract][Full Text] [Related]
10. Canine mammary tumour cell lines established in vitro.
Hellmén E
J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
[TBL] [Abstract][Full Text] [Related]
11. Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography.
Hirayama K; Yokota H; Onai R; Kobayashi T; Kumata T; Kihara K; Okamoto M; Sako T; Nakade T; Izumisawa Y; Taniyama H
J Comp Pathol; 2002 Nov; 127(4):249-56. PubMed ID: 12443732
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of eight feline mammary adenocarcinoma cell lines.
Uyama R; Hong SH; Nakagawa T; Yazawa M; Kadosawa T; Mochizuki M; Tsujimoto H; Nishimura R; Sasaki N
J Vet Med Sci; 2005 Dec; 67(12):1273-6. PubMed ID: 16397390
[TBL] [Abstract][Full Text] [Related]
13. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
Ferletta M; Grawé J; Hellmén E
Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM-B2 by sodium phenylacetate.
Watanabe M; Sugano S; Imai J; Yoshida K; Onodera R; Amin MR; Uchida K; Yamaguchi R; Tateyama S
Res Vet Sci; 2001 Feb; 70(1):27-32. PubMed ID: 11170848
[TBL] [Abstract][Full Text] [Related]
15. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
16. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
[TBL] [Abstract][Full Text] [Related]
17. Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system.
Sánchez-Céspedes R; Maniscalco L; Iussich S; Martignani E; Guil-Luna S; De Maria R; Martín de Las Mulas J; Millán Y
Vet J; 2013 Aug; 197(2):474-82. PubMed ID: 23583698
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemistry of intermediate filaments in cultured arterial smooth muscle cells: differences in desmin and vimentin expression related to cell of origin and/or plating time.
Sakata N; Kawamura K; Fujimitsu K; Chiang YY; Takebayashi S
Exp Mol Pathol; 1990 Oct; 53(2):126-39. PubMed ID: 2261944
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas.
Martín de las Mulas J; Espinosa de los Monteros A; Bautista MJ; Gómez-Villamandos JC; Morales C
J Comp Pathol; 1994 Nov; 111(4):365-81. PubMed ID: 7533801
[TBL] [Abstract][Full Text] [Related]
20. A cell line (MCA-B1) derived from a canine oral acanthomatous epulis.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K; Ogawa H; Nakai M
Res Vet Sci; 1995 Jan; 58(1):101-2. PubMed ID: 7709052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
